Clinical trial
Treatment for Subjects With Active Rheumatoid Arthritis (RA)
NCT00110903 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00110903 |
|---|---|
| Title | Treatment for Subjects With Active Rheumatoid Arthritis (RA) |
| Official title | Open-Label Study to Assess the Safety of Etanercept Liquid Administered Once Weekly in Subjects With Active Rheumatoid Arthritis (RA) |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Etanercept Liquid |
| First posted | May 17, 2005 |
| Last update posted | Apr 26, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: